|
Acute Myeloid Leukemia and Myelodysplastic Syndromes in Older Adults
|
Jul 2014
|
J Clin Oncol
|
myelodysplastic syndromes (MDS)
|
|
Adding molecular data to prognostic models can improve predictive power in treated patients with myelodysplastic syndromes
|
Aug 2017
|
Leukemia
|
|
|
Adequate iron chelation therapy for at least six months improves survival in transfusion-dependent patients with lower risk myelodysplastic syndromes
|
Feb 2014
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
|
Albumin as a prognostic marker in myelodysplastic syndromes: still relevant after all these years
|
May 2015
|
Leuk Lymphoma
|
myelodysplastic syndromes (MDS)
|
|
Alcohol use is not a significant contributor to myelodysplastic syndromes
|
Apr 2020
|
Cancer Causes & Control : CCC
|
myelodysplastic syndromes (MDS)
|
|
Allogeneic BM transplantation for the treatment of aplastic anemia: current results and expanding donor possibilities
|
Dec 2013
|
Hematology Am Soc Hematol Educ Program
|
aplastic anemia
|
|
Allogeneic haematopoietic stem cell transplantation in myelodysplastic syndromes
|
Sep 2014
|
Curr Opin Oncol
|
myelodysplastic syndromes (MDS)
|
|
Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndromes - Lingering Uncertainties and Emerging Possibilities
|
Jul 2014
|
Biol Blood Marrow Transplant
|
myelodysplastic syndromes (MDS)
|
|
Allogeneic hematopoietic cell transplantation for severe aplastic anemia: similar long-term overall survival after transplantation with related donors compared to unrelated donors
|
Oct 2015
|
Bone Marrow Transplant
|
aplastic anemia
|
|
Allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndromes
|
Oct 2012
|
Semin Hematol
|
myelodysplastic syndromes (MDS)
|
